InventisBio Co., Limited (SHA:688382)
China
· Delayed Price · Currency is CNY 21.39
+1.42 (7.11%)
Mar 6, 2026, 4:00 PM EST
InventisBio Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Net Income | - | -240.2 | -283.98 | -483.49 | -357.91 | Upgrade
|
| Depreciation & Amortization | - | 18.61 | 17.33 | 15.61 | 11.1 | Upgrade
|
| Other Amortization | - | 1.37 | 4.88 | 4.31 | 3.79 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | -0.08 | - | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | -1.3 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | -6.56 | - | - | Upgrade
|
| Stock-Based Compensation | - | - | - | - | 33.4 | Upgrade
|
| Provision & Write-off of Bad Debts | - | 8.88 | 9.29 | - | - | Upgrade
|
| Other Operating Activities | - | -22.8 | -3.91 | -20.93 | 12.33 | Upgrade
|
| Change in Accounts Receivable | - | 13.96 | -164.16 | -32.68 | -0.96 | Upgrade
|
| Change in Accounts Payable | - | -67.87 | 50.49 | 9.45 | 46.19 | Upgrade
|
| Change in Other Net Operating Assets | - | 47.45 | 68.86 | 30.84 | -0 | Upgrade
|
| Operating Cash Flow | - | -241.97 | -307.75 | -476.89 | -252.07 | Upgrade
|
| Capital Expenditures | - | -7.56 | -6.29 | -7.69 | -26.52 | Upgrade
|
| Investment in Securities | - | -67.52 | -700 | - | - | Upgrade
|
| Other Investing Activities | - | 21.15 | 6.95 | - | - | Upgrade
|
| Investing Cash Flow | - | -53.93 | -699.33 | -7.69 | -26.52 | Upgrade
|
| Long-Term Debt Issued | - | - | 16.29 | - | - | Upgrade
|
| Total Debt Issued | - | - | 16.29 | - | - | Upgrade
|
| Long-Term Debt Repaid | - | - | -16.29 | -12.92 | -9.23 | Upgrade
|
| Total Debt Repaid | - | - | -16.29 | -12.92 | -9.23 | Upgrade
|
| Net Debt Issued (Repaid) | - | - | - | -12.92 | -9.23 | Upgrade
|
| Issuance of Common Stock | - | 7.59 | - | 2,000 | - | Upgrade
|
| Other Financing Activities | - | -14.07 | -13.57 | -13.09 | -6.69 | Upgrade
|
| Financing Cash Flow | - | -6.48 | -13.57 | 1,974 | -15.91 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | 0.5 | 1.27 | 21.95 | -13.18 | Upgrade
|
| Net Cash Flow | - | -301.88 | -1,019 | 1,511 | -307.68 | Upgrade
|
| Free Cash Flow | - | -249.53 | -314.04 | -484.59 | -278.59 | Upgrade
|
| Free Cash Flow Margin | - | -147.84% | -169.27% | - | - | Upgrade
|
| Free Cash Flow Per Share | - | -0.43 | -0.55 | -0.95 | -0.61 | Upgrade
|
| Cash Interest Paid | - | - | 0.18 | - | - | Upgrade
|
| Cash Income Tax Paid | - | -7.53 | -27.06 | -7.82 | -10.22 | Upgrade
|
| Levered Free Cash Flow | - | -163.01 | -245.48 | -286.5 | -173.17 | Upgrade
|
| Unlevered Free Cash Flow | - | -162.59 | -244.96 | -285.85 | -172.43 | Upgrade
|
| Change in Working Capital | - | -6.46 | -44.81 | 7.6 | 45.23 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.